Scientists test 'Off-the-Shelf' cell therapy to reset immune system in devastating autoimmune diseases
NCT ID NCT07315087
Summary
This early-phase study is testing a new type of cell therapy called QT-019C for people with severe autoimmune diseases that have not improved with standard treatments. The therapy uses donated, 'universal' immune cells engineered to target and remove harmful immune cells. The main goals are to see if the one-time infusion is safe and if it can help control these difficult diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology & Blood Diseases Hospital
RECRUITINGTianjin, China, China
Conditions
Explore the condition pages connected to this study.